CMS certification 230089
Beaumont Hospital - Grosse Pointe
468 Cadieux Rd, Grosse Pointe, MI 48230
Beaumont Hospital - Grosse Pointe has a CMS overall rating of 4 out of 5 stars. 67% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 2. Emergency patients spend a median of 2 h 42 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 880 completed surveys, 20% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | MI | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 415 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 42 min | 2 h 39 min | 2 h 42 min |
| Left before being seen Lower is better · 73,931 patients | 3% | 3% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 15 patients | 73% | 72% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 120 patients | 48% | 60% | 65% |
How Beaumont Hospital - Grosse Pointe compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Beaumont Hospital - Grosse PointeThis hospital | 4/5 | 67% | 2 h 42 min | 4 better 2 worse |
| Sinai-Grace HospitalSame county · Detroit | 1/5 | 35% | 2 h 23 min | 2 better 3 worse |
| Henry Ford Health St John HospitalSame county · Detroit | 1/5 | 56% | 2 h 50 min | 2 better 2 worse |
| Henry Ford Health HospitalSame county · Detroit | 3/5 | 72% | 3 h 28 min | 4 better 7 worse |
| Detroit (john D. Dingell) VA Medical CenterSame county · Detroit | 5/5 | 70% | — | 4 better |
| Detroit Receiving HospitalSame county · Detroit | 1/5 | 43% | 2 h 19 min | 2 better 1 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 2,168 cases | Too few cases | 2.8% | 3.9% |
| Heart attack 51 cases | Too few cases | 10.4% | 11.9% |
| Heart failure 326 cases | Too few cases | 9.2% | 11.1% |
| Pneumonia 270 cases | Too few cases | 11.4% | 15.2% |
| Stroke 106 cases | Too few cases | 10.5% | 11.9% |
| COPD 154 cases | Too few cases | 8.1% | 8.6% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.77 likely 0.41 – 1.13 | 1 |
| After hip or knee replacement 110 cases | Too few cases | 3.7% | 4.1% |
| Deaths after a serious but treatable surgical complication 27 cases | No different | 165.27 per 1,000 likely 102.77 per 1,000 – 227.77 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 3,829 cases | No different | 0.18 per 1,000 likely 0 per 1,000 – 0.92 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 4,640 cases | No different | 0.17 per 1,000 likely 0 per 1,000 – 0.38 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 4,766 cases | No different | 0.23 per 1,000 likely 0.03 per 1,000 – 0.42 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 712 cases | No different | 2 per 1,000 likely 0.4 per 1,000 – 3.61 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 273 cases | No different | 1.58 per 1,000 likely 0 per 1,000 – 3.27 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 290 cases | No different | 6.1 per 1,000 likely 0 per 1,000 – 14.31 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 790 cases | No different | 3.93 per 1,000 likely 1.71 per 1,000 – 6.15 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 266 cases | No different | 5.04 per 1,000 likely 1.12 per 1,000 – 8.95 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 264 cases | No different | 1.62 per 1,000 likely 0.15 per 1,000 – 3.09 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 811 cases | No different | 1.11 per 1,000 likely 0.12 per 1,000 – 2.1 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.52 likely 0.09 – 1.72 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.38 likely 0.06 – 1.25 | 1 |
| Surgical site infections after colon surgery | No different | 1.5 likely 0.61 – 3.12 | 1 |
| Surgical site infections after abdominal hysterectomy | Worse | 4.08 likely 1.5 – 9.05 | 1 |
| MRSA bloodstream infections | No different | 1.15 likely 0.29 – 3.12 | 1 |
| C. diff intestinal infections | Better | 0.29 likely 0.12 – 0.61 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 64 cases | Too few cases | 14.5% | 14.4% |
| Readmitted after heart failure 713 cases | Too few cases | 21.6% | 21.3% |
| Readmitted after pneumonia 480 cases | Too few cases | 16.9% | 17.3% |
| Readmitted after COPD 307 cases | Too few cases | 19.5% | 20% |
| Readmitted after hip or knee replacement 99 cases | Too few cases | 5.1% | 5.8% |
| Days back in hospital after heart failure 399 cases | Too few cases | -8.1 days per 100 | — |
| Days back in hospital after pneumonia 275 cases | Too few cases | 1.8 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 644 cases | No different | 11.7 per 1,000 likely 8.7 per 1,000 – 15.6 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 93 cases | No different | 10.9 per 100 likely 7.8 per 100 – 14.9 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 93 cases | No different | 4.7 per 100 likely 3.1 per 100 – 7 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 345 cases | No different | 0.9 likely 0.7 – 1.2 | — |
3 more measures had too few cases here to report.
Clinicians registered at this address
197 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Nurse Anesthetist, Certified Registered | 30 |
| Physician Assistant | 30 |
| Family Medicine | 27 |
| Nurse Practitioner | 13 |
| Emergency Medicine | 12 |
| Family | 10 |
| Physical Therapist | 9 |
| Diagnostic Radiology | 8 |
| Internal Medicine | 8 |
| Occupational Therapist | 8 |
| Anesthesiology | 4 |
| Medical | 4 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $6.7M
- 2020 $3M
- 2021 $9M
- 2022 $913,364
- 2023 $535,292
- 2024 $3.4M
- 2025 $1.5M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $84,940 | 13 |
| Space rental and facility fees | $60,643 | 20 |
| Speaking, teaching and other services | $33,460 | 11 |
| Grants | $21,450 | 10 |
| Consulting fees | $4,722 | 2 |
| Debt forgiveness | $4,504 | 3 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $281,633 | 24 |
| United Therapeutics Corporation | $235,357 | 42 |
| Pfizer INC. | $153,286 | 42 |
| Imperative Care, Inc | $141,505 | 3 |
| Boston Scientific Corporation | $100,215 | 20 |
| ModernaTX, Inc. | $97,184 | 2 |
| AngioDynamics, Inc. | $60,000 | 1 |
| Janssen Research & Development, LLC | $56,632 | 16 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| THE IMPERATIVE TRIAL: TREATMENT OF ACUTE ISCHEMIC STROKE WITH THE ZOOM REPERFUSION SYSTEM Imperative Care, Inc | $141,505 |
| A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Idiopat… Boehringer Ingelheim Pharmaceuticals, Inc. | $118,635 |
| Comparing outcomes in COVID-19, RSV, and Influenza infections ModernaTX, Inc. | $97,184 |
| A PHASE 4 STUDY USING A TESTNEGATIVE DESIGN TO EVALUATE THE EFFECTIVENESS OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE AGAINST VACCINETYPE RADIOLOGIC… PFIZER INC. | $90,228 |
| A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Prog… United Therapeutics Corporation · NCT05943535 | $88,145 |
| A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonar… United Therapeutics Corporation · NCT04708782 | $80,241 |
| A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Progres… Boehringer Ingelheim Pharmaceuticals, Inc. | $74,695 |
| An open-label extension trial of the long-term safety and efficacy of BI 1015550 taken orally in patients with idiopathic pulmonary fibrosis (IPF) an… Boehringer Ingelheim Pharmaceuticals, Inc. | $72,975 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Beaumont Hospital - Grosse Pointe
Is Beaumont Hospital - Grosse Pointe a good hospital?
Beaumont Hospital - Grosse Pointe has a CMS overall rating of 4 out of 5 stars. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 2. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Beaumont Hospital - Grosse Pointe?
67% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 880 completed HCAHPS surveys.
How long is the wait in the Beaumont Hospital - Grosse Pointe emergency room?
Emergency patients spend a median of 2 h 42 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 3% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Beaumont Hospital - Grosse Pointe receive money from drug and device companies?
Drug and device makers reported $1.5M in payments to Beaumont Hospital - Grosse Pointe for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.